Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00155337
Collaborator
(none)
40
1
40
1

Study Details

Study Description

Brief Summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Condition or Disease Intervention/Treatment Phase
  • Procedure: photodynamic therapy
Phase 4

Detailed Description

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Study Start Date :
Aug 1, 2004
Actual Primary Completion Date :
Dec 1, 2007
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

  1. End of 8 treatments []

Secondary Outcome Measures

  1. Regression of lesions []

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with leukoplakia or erythroleukoplakia
Exclusion Criteria:
  • oral cancers

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Taiwan University Hospital Taipei Taiwan 100

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

  • Principal Investigator: Chun-Pin Chiang, DMSc, National Taiwan University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00155337
Other Study ID Numbers:
  • 9361700753
First Posted:
Sep 12, 2005
Last Update Posted:
Dec 21, 2012
Last Verified:
Dec 1, 2012
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2012